Genetic Characterization of a Novel Model of Cleft Palate

腭裂新模型的遗传特征

基本信息

  • 批准号:
    7739362
  • 负责人:
  • 金额:
    $ 13.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Orofacial clefting is one of the most common birth defects in humans, affecting approximately 1 in 700 live births. This frequency likely stems from the complexity of craniofacial morphogenesis, which requires precise regulation of gene expression changes, alterations in cell physiology and morphogenic movements. Although an increasing number of genes have been linked to cleft lip and cleft palate, the mechanisms governing orofacial malformations remain unclear. The overall objective of this project is to expand our understanding of the genetic basis of orofacial clefting through the use of a novel mouse model of cleft palate. The ENU-induced clfp4 mouse harbors a recessive mutation causing cleft secondary palate, omphalocele and skeletal malformations with high penetrance. While simultaneous presentation of orofacial clefting and body wall defects is observed in human syndromes, there are few mouse models that recapitulate these phenotypes. Preliminary mapping data places the mutation at the distal end of Chromosome 10, a region where this combination of phenotypes has not been reported. Thus, clfp4 likely represents a new model of craniofacial/body wall birth defects. Although preliminary phenotypic analysis has revealed that cleft palate in this mutant results from a failure of palate shelf elevation, efficient design and interpretation of more detailed experiments, such as marker analysis, would be greatly facilitated by identification of the clfp4 causative gene. To develop this unique model of cleft palate and to elucidate the mechanism underlying the phenotype, we propose to identify the gene that underlies the cflp4 mutation through high-resolution genetic mapping and targeted re-sequencing, and perform basic phenotypic analysis to begin to understand the mechanistic basis of the defect. This work will improve our understanding of the molecular networks that regulate palatogenesis, providing a foundation for the development of new methods for the diagnosis, prevention and treatment of cleft palate and other craniofacial disorders. PUBLIC HEALTH RELEVANCE: Orofacial clefting is one of the most common birth defects in humans, affecting 1 in 700 live births. The total health care costs for surgical repair and post-operative therapies is staggering, and the disfigurement of such disorders often have devastating social and psychological consequences for the affected individual. This proposal will expand our understanding of the etiology of orofacial clefting using a novel mouse model of cleft palate and craniofacial malformations, providing a foundation for the development of new methods for the diagnosis, prevention and treatment of cleft palate and other craniofacial disorders.
描述(由申请人提供):口面裂是人类最常见的出生缺陷之一,影响大约1/700的活产婴儿。这种频率可能源于颅面形态发生的复杂性,这需要精确调节基因表达变化、细胞生理学改变和形态发生运动。虽然越来越多的基因与唇裂和腭裂有关,但控制口面畸形的机制仍不清楚。本项目的总体目标是通过使用一种新的腭裂小鼠模型来扩大我们对口面裂遗传基础的理解。ENU诱导的clfp 4小鼠携带隐性突变,导致继发性腭裂、脐膨出和骨骼畸形,具有高突变率。虽然在人类综合征中观察到口面裂和体壁缺陷的同时呈现,但很少有小鼠模型重现这些表型。初步定位数据将突变定位在染色体10的远端,该区域的表型组合尚未报道。因此,clfp 4可能代表一种新的颅面/体壁出生缺陷模型。虽然初步的表型分析表明,腭裂在这个突变体的结果从失败的腭架海拔,有效的设计和更详细的实验,如标记分析的解释,将大大促进clfp 4致病基因的鉴定。为了开发这种独特的腭裂模型并阐明表型的机制,我们建议通过高分辨率遗传图谱和靶向重测序来识别cflp 4突变的基因,并进行基本的表型分析,以开始了解缺陷的机制基础。这项工作将提高我们对调节腭裂发生的分子网络的理解,为开发诊断,预防和治疗腭裂和其他颅面疾病的新方法提供基础。 公共卫生相关性:口面裂是人类最常见的出生缺陷之一,每700个活产婴儿中就有1个受到影响。手术修复和术后治疗的总保健费用是惊人的,这种疾病的毁容往往对受影响的个人产生毁灭性的社会和心理后果。该建议将扩大我们的口面裂的病因学的理解,使用一种新的腭裂和颅面畸形的小鼠模型,提供了一个基础,为腭裂和其他颅面疾病的诊断,预防和治疗的新方法的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen A Murray其他文献

A resource of targeted mutant mouse lines for 5,061 genes
5,061 个基因的靶向突变小鼠品系资源
  • DOI:
    10.1101/844092
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Birling;Atsushi Yoshiki;David J. Adams;Shinya Ayabe;Arthur L Beaudet;Joanna Bottomley;Allan Bradley;Steve D M Brown;Antje Bürger;Wendy Bushell;Francesco Chiani;Hsian;Skevoulla Christou;G. Codner;Francesco J. DeMayo;Francesco J. DeMayo;Mary E. Dickinson;B. Doe;Leah Rae Donahue;M. Fray;A. Gambadoro;Xiang Gao;Marina Gertsenstein;A. Gomez;Leslie O. Goodwin;Jason D. Heaney;Yann Hérault;M. Angelis;Si;Monica J. Justice;P. Kasparek;R. King;Ralf Kühn;Ho Lee;Young Jae Lee;Zhiwei Liu;K. C. K. Lloyd;I. Lorenzo;A. Mallon;C. McKerlie;T. Meehan;Stuart Newman;L. Nutter;Goo Taeg Oh;G. Pavlovic;R. Ramírez‐Solís;B. Rosen;Edward Ryder;Luis Santos;J. Schick;J. Seavitt;R. Sedláček;C. Seisenberger;Je Kyung Seong;W. Skarnes;T. Sorg;Karen P. Steel;Masaru Tamura;G. Tocchini;Chi;H. Wardle;Marie Wattenhofer;Sara Wells;Brandon J. Willis;J. A. Wood;W. Wurst;Ying Xu;L. Teboul;Stephen A Murray
  • 通讯作者:
    Stephen A Murray

Stephen A Murray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen A Murray', 18)}}的其他基金

Preclinical Mouse Model Core
临床前小鼠模型核心
  • 批准号:
    10668764
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
Disease Modeling Unit
疾病模型单位
  • 批准号:
    10251358
  • 财政年份:
    2020
  • 资助金额:
    $ 13.05万
  • 项目类别:
Disease Modeling Unit
疾病模型单位
  • 批准号:
    10469586
  • 财政年份:
    2020
  • 资助金额:
    $ 13.05万
  • 项目类别:
Animal Model Production Section
动物模型制作科
  • 批准号:
    10450129
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
Coordination Section
协调科
  • 批准号:
    10223457
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
Resource Section
资源部分
  • 批准号:
    10223459
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
Animal Model Production Section
动物模型制作科
  • 批准号:
    10223460
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
Coordination Section
协调科
  • 批准号:
    10450125
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
Resource Section
资源部分
  • 批准号:
    10450127
  • 财政年份:
    2018
  • 资助金额:
    $ 13.05万
  • 项目类别:
CRE Driver Strain Resources
CRE 驾驶员应变资源
  • 批准号:
    10450123
  • 财政年份:
    2011
  • 资助金额:
    $ 13.05万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 13.05万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 13.05万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 13.05万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了